-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Biomarin Pharmaceutical Inc annual Current State and Local Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Biomarin Pharmaceutical Inc annual Current State and Local Tax Expense (Benefit) for 2023 was $5.1 M, a 0.79% increase from 2022.
- Biomarin Pharmaceutical Inc annual Current State and Local Tax Expense (Benefit) for 2022 was $5.06 M, a 278% increase from 2021.
- Biomarin Pharmaceutical Inc annual Current State and Local Tax Expense (Benefit) for 2021 was $1.34 M, a 34.2% increase from 2020.
Current State and Local Tax Expense (Benefit), Annual Data (USD)